Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Atherosclerotic cardiovascular disease (CVD) is on course to surpass infectious diseases as the leading cause of morbidity and mortality worldwide.1 Multiple risk factors are responsible for this trend including the increasing average life expectancy and reducing rates of communicable diseases in addition to potentially modifiable risk factors, such as tobacco use, hypertension, hyperlipidemia, and diabetes mellitus.1 The development of atherosclerosis is driven by multiple factors including hypertension, dyslipidemia, inflammation, insulin resistance, and hyperglycemia.While many techniques are available to accurately measure atherosclerosis (coronary artery calcium scanning, CT angiography, intravascular ultrasound), understanding the pathophysiology of the disease may help drive discovery to ultimately prevent the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fishman, S. L., Sonmez, H., Basman, C., Singh, V., & Poretsky, L. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0060-3 · Cited by 330
Cavero-Redondo, I., Peleteiro, B., Álvarez-Bueno, C., Rodriguez-Artalejo, F., & Martínez-Vizcaíno, V. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-015949 · Cited by 260
Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
Li, B., Li, W., Li, X., & Zhou, H. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161230142931 · Cited by 130 · cited 9×
“Helper T (TH) cells have multiple subtypes; most notably, TH1 cells are clearly atherogenic, whereas regulatory T cells (Tregs) are atheroprotective; the other subtypes do not yet have clearly defined roles.(11) The protein component of the LDL particle is presented by macrophages and dendritic cells to COMMENTARY 103”
BackgroundInfluentialPendergrass, M., Bertoldo, A., Bonadonna, R., Nucci, G., Mandarino, L., Cobelli, C., & DeFronzo, R. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00617.2005 · Cited by 87 · cited 2×
“Nitric oxide synthase is activated through the same PI-3–kinase pathway; the resultant decrease in nitric oxide production leads to endothelial dysfunction and accelerated atherosclerosis.(4)”
Background
Cited by
Ding, X., Wang, X., Wu, J., Zhang, M., & Cui, M. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01268-9 · Cited by 454
Ponce-Lopez, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094209 · Cited by 75
Nuñez-Selles, A. J., Nuñez-Musa, R. A., & Guillen-Marmolejos, R. A. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1611842 · Cited by 51
Unraveling PCOS: Exploring its causes and diagnostic challenges
Dar, M. A., Maqbool, M., Qadrie, Z., Ara, I., & Qadir, A. (2024) · Open Health · doi:10.1515/ohe-2023-0026 · Cited by 7
Metadata
- Authors
- Beverly, J. K., & Budoff, M. J.
- Venue
- Journal of Diabetes
- Publisher
- Wiley
- Published
- 2019-08-14
- Volume
- 12
- Issue
- 2
- Pages
- 102-104
- ISSN
- 1753-0393 (ISSN-L)
- 1753-0407
- OpenAlex
- W2967976623
- Cited by
- 214
- References
- 4
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation. https://app.cochat.ai/papers/10.1111/1753-0407.12970
- The paper
- Beverly, J. K., & Budoff, M. J. (2020). Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation. Journal of Diabetes. https://doi.org/10.1111/1753-0407.12970
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.